May-21
Cardiovascular Men's Health Oncology Pharmacoepidemiology
Read moreMar-21
Jan-21
Jan-21
Hepatology Oncology Pharmacoepidemiology
Read moreNov-20
Gastroenterology Oncology Pharmacoepidemiology
Read moreSep-20
Sep-20
Aug-20
Demographics Oncology Respiratory
Read moreJul-20
Dermatology Oncology Pharmacoepidemiology
Read moreMay-20
Gastroenterology Men's Health Oncology Pharmacoepidemiology
Read moreMar-20
Date | Title | Categories | |
---|---|---|---|
May-21 | Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases | Read more | |
Mar-21 | Reviewing the impact of 11 national Be Clear on Cancer public awareness campaigns, England, 2012 to 2016: A synthesis of published evaluation results | Read more | |
Jan-21 | Angiotensin converting enzyme inhibitors and the risk of hepatocellular cancer: a nested cohort analysis | Read more | |
Jan-21 | Digoxin use is associated with pancreatic cancer risk but does not affect survival | Read more | |
Nov-20 | Low-dose aspirin and risk of gastric and oesophageal cancer: a population-based study in the United Kingdom using The Health Improvement Network | Read more | |
Sep-20 | Long-term trends in lung cancer incidence in UK non-smokers: a cohort study of 3.7 million people | Read more | |
Sep-20 | Long-term trends in lung cancer incidence in non-smokers: a UK-based cohort study of 3.7 million people | Read more | |
Aug-20 | Twenty-year sociodemographic trends in lung cancer in non-smokers: A UK-based cohort study of 3.7 million people | Read more | |
Jul-20 | Association between hydrochlorothiazide exposure and different incident skin, lip and oral cavity cancers: a series of population-based nested case-control studies | Read more | |
Jun-20 | Be Clear on Cancer: Fourth national blood in pee campaign, 2018 | Read more | |
May-20 | No association between use of phosphodiesterase 5 inhibitors and colorectal cancer in men with erectile dysfunction | Read more | |
Mar-20 | The use of electronic healthcare records for colorectal cancer screening referral decisions and risk prediction model development | Read more |